|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,165.00 JPY | +2.75% |
|
+2.84% | -22.38% |
| 04-13 | Cosmos Pharmaceutical's Nine-Month Profit Rises 1.8% | MT |
| 04-13 | Cosmos Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 7,975 | +29.36% | 10 | ||||||
| 2,541.11 | +27.12% | 9 | ||||||
| 3,537.78 | +14.42% | 9 | ||||||
| 4,745.71 | +24.66% | 7 | ||||||
| - | 3,826 | +8.29% | 5 | |||||
| 18.6 | +69.28% | 11 | ||||||
| - | 90 | +23.63% | 2 | |||||
| Average | 3,247.74 | +28.11% | 8 | ||||||
| Weighted average by Cap. | 3,876.29 | +25.36% | 8 |
- Stock Market
- Stocks
- 3349 Stock
- Sector COSMOS Pharmaceutical Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
